Ibere Pharmaceuticals Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GLAZER CAPITAL, LLC | 02/14/2023 | 1.33 M | $13.42 M | 22.42% | 7.71% |
| MAGNETAR FINANCIAL LLC | 02/14/2023 | 785,872 | $7.93 M | 0.00% | 4.56% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2023 | 716,613 | $7.23 M | 0.00% | 4.15% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 02/14/2023 | 678,918 | $6.85 M | 0.00% | 3.94% |
| ARISTEIA CAPITAL LLC | 02/14/2023 | 675,173 | $6.81 M | 58.80% | 3.91% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2023 | 660,664 | $6.67 M | 1.23% | 3.83% |
| FIRST TRUST CAPITAL MANAGEMENT L.P. | 02/14/2023 | 542,852 | $5.48 M | 0.00% | 3.15% |
| MARSHALL WACE, LLP | 02/14/2023 | 539,807 | $5.45 M | 0.00% | 3.13% |
| PERISCOPE CAPITAL INC. | 02/13/2023 | 470,395 | $4.75 M | 3.12% | 2.73% |
| KIM, LLC | 02/14/2023 | 450,000 | $4.54 M | 0.00% | 2.61% |
| LINDEN ADVISORS LP | 02/14/2023 | 450,000 | $4.54 M | 0.00% | 2.61% |
| SCULPTOR CAPITAL LP | 02/14/2023 | 425,000 | $4.29 M | 0.00% | 2.46% |
| VESTCOR INC | 02/15/2023 | 400,000 | $4.04 M | 0.00% | 2.32% |
| SABA CAPITAL MANAGEMENT, L.P. | 02/14/2023 | 355,704 | $3.59 M | 8.12% | 2.06% |
| COHANZICK MANAGEMENT, LLC | 02/13/2023 | 345,252 | $3.48 M | -0.89% | 2.00% |
| RADCLIFFE CAPITAL MANAGEMENT, L.P. | 02/17/2023 | 327,150 | $3.30 M | 0.00% | 1.90% |
| HSBC HOLDINGS PLC | 02/14/2023 | 325,108 | $3.28 M | 100.00% | 1.88% |
| BANK OF AMERICA CORP /DE/ | 02/10/2023 | 320,000 | $3.23 M | 0.00% | 1.86% |
| NOMURA HOLDINGS INC | 02/15/2023 | 318,644 | $3.21 M | 0.00% | 1.85% |
| MOORE CAPITAL MANAGEMENT, LP | 02/14/2023 | 300,000 | $3.03 M | 0.00% | 1.74% |
| CASTLE CREEK ARBITRAGE, LLC | 02/14/2023 | 253,446 | $2.56 M | 0.00% | 1.47% |
| WESTCHESTER CAPITAL MANAGEMENT, LLC | 02/14/2023 | 243,944 | $2.46 M | 100.00% | 1.41% |
| AQR ARBITRAGE LLC | 02/14/2023 | 206,415 | $2.08 M | 0.00% | 1.20% |
| PICTON MAHONEY ASSET MANAGEMENT | 02/13/2023 | 200,000 | $2.02 M | 0.00% | 1.16% |
| D. E. SHAW & CO., INC. | 02/14/2023 | 150,000 | $1.51 M | -45.46% | 0.87% |
| CANTOR FITZGERALD, L. P. | 02/14/2023 | 112,050 | $1.13 M | 0.00% | 0.65% |
| WALLEYE CAPITAL LLC | 02/14/2023 | 110,048 | $1.11 M | 0.00% | 0.64% |
| FIR TREE CAPITAL MANAGEMENT LP | 02/14/2023 | 82,037 | $827,753 | -0.20% | 0.48% |
| WALLEYE TRADING LLC | 02/14/2023 | 80,000 | $807,200 | 0.00% | 0.46% |
| WHITEBOX ADVISORS LLC | 02/14/2023 | 75,246 | $759,232 | 0.00% | 0.44% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2023 | 74,547 | $752,179 | 5.79% | 0.43% |
| BERKLEY W R CORP | 02/14/2023 | 69,176 | $697,986 | 0.58% | 0.40% |
| JANUS HENDERSON GROUP PLC | 02/14/2023 | 52,917 | $533,933 | 0.00% | 0.31% |
| LYNWOOD CAPITAL MANAGEMENT INC. | 02/07/2023 | 51,400 | $519,000 | 0.00% | 0.30% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 50,995 | $514,540 | 0.00% | 0.30% |
| HGC INVESTMENT MANAGEMENT INC. | 02/14/2023 | 49,023 | $495,000 | 100.00% | 0.28% |
| KNOTT DAVID M JR | 02/13/2023 | 36,000 | $363,000 | 0.00% | 0.21% |
| SILVERBACK ASSET MANAGEMENT LLC | 02/14/2023 | 30,000 | $302,700 | 0.00% | 0.17% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 29,367 | $296,313 | 0.00% | 0.17% |
| WOLVERINE ASSET MANAGEMENT LLC | 02/01/2023 | 28,841 | $291,005 | 100.00% | 0.17% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 02/10/2023 | 25,000 | $252,250 | 0.00% | 0.14% |
| EXOS TFP HOLDINGS LLC | 02/10/2023 | 22,792 | $229,971 | 100.00% | 0.13% |
| DEEPCURRENTS INVESTMENT GROUP LLC | 02/14/2023 | 17,730 | $178,896 | 0.00% | 0.10% |
| DARK FOREST CAPITAL MANAGEMENT LP | 02/13/2023 | 15,574 | $157,142 | 0.00% | 0.09% |
| ROBINSON CAPITAL MANAGEMENT, LLC | 02/14/2023 | 9,557 | $96,430 | 0.00% | 0.06% |
| CLEAR STREET LLC | 02/13/2023 | 1,543 | $16,000 | 100.00% | 0.01% |
| UBS GROUP AG | 02/08/2023 | 544 | $5,489 | -73.91% | 0.00% |
| OLD MISSION CAPITAL LLC | 02/14/2023 | 383 | $3,864 | 100.00% | 0.00% |
| COWEN AND COMPANY, LLC | 02/09/2023 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ibere Pharmaceuticals institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Ibere Pharmaceuticals. The most heavily invested institutionals were:
SPRING CREEK CAPITAL LLC: 400,000
Omni Partners US LLC: 58,552
KNOTT DAVID M: 36,000
72.44% of Ibere Pharmaceuticals stock is owned by institutional investors.
Institutional investors have bought a total of 494,552 shares in the last 24 months. This purchase volume represents approximately $5.03 M in transactions.